Cargando…
Nitrosylcobalamin Potentiates the Anti-Neoplastic Effects of Chemotherapeutic Agents via Suppression of Survival Signaling
BACKGROUND: Nitrosylcobalamin (NO-Cbl) is a chemotherapeutic pro-drug derived from vitamin B12 that preferentially delivers nitric oxide (NO) to tumor cells, based upon increased receptor expression. NO-Cbl induces Apo2L/TRAIL-mediated apoptosis and inhibits survival signaling in a variety of malign...
Autores principales: | Bauer, Joseph A., Lupica, Joseph A., Schmidt, Heidi, Morrison, Bei H., Haney, Rebecca M., Masci, Rhonda K., Lee, Rebecca M., DiDonato, Joseph A., Lindner, Daniel J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2117345/ https://www.ncbi.nlm.nih.gov/pubmed/18074035 http://dx.doi.org/10.1371/journal.pone.0001313 |
Ejemplares similares
-
Spectral
and Electronic Properties of Nitrosylcobalamin
por: Pallares, Ivan G., et al.
Publicado: (2014) -
Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-κB and proinflammatory gene program activation in intestinal epithelial cells
por: Tallant, Thomas, et al.
Publicado: (2004) -
Apolipoprotein A-I and Cancer
por: Zamanian-Daryoush, Maryam, et al.
Publicado: (2015) -
Suppression of Steady-state, but not Stimulus-induced NF-κB Activity Inhibits Alphavirus-induced Apoptosis
por: Lin, Kuo-I, et al.
Publicado: (1998) -
Evaluation of Chemotherapeutic Agents
por: Engstrom, W. W.
Publicado: (1949)